NEXGENIX PHARMACEUTICALS
NexGenix is a privately-held drug discovery and development company focused on the "next generation" of targeted therapies for cancer and diseases of the nervous system such as glioblastoma, neurodegenerative diseases, neurofibromatosis, and autism-spectrum disorders. The Company has acquired, through in-licensing and research collaboration, a robust structural chemistry platform in resorcylic macrolides, highly potent inhibitors of the chaperone, heat shock protein 90 (Hsp90). The concept that ... numerous diseases, including cancer, neurofibromatosis, amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and Parkinson's disease involve misregulation of protein homeostasis presents a unique opportunity for drug development for these varied disorders. NexGenix's novel Hsp90 inhibitors, based on the highly potent compound radicicol, exhibit the potential to be best in class drugs.
NEXGENIX PHARMACEUTICALS
Industry:
Biotechnology Medical
Founded:
2003-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.nexgenixpharm.com
Total Employee:
1+
Status:
Active
Contact:
(917)210-3377
Email Addresses:
[email protected]
Total Funding:
3.9 M USD
Technology used in webpage:
Microsoft Azure DNS GoDaddy DNS GoDaddy Premium DNS AppRiver Weebly Hosting
Similar Organizations
Genervon Biopharmaceuticals
Genervon Biopharmaceuticals is a biotechnology company.
Investors List
Infinity Investment Group
Infinity Investment Group investment in Series B - NexGenix Pharmaceuticals
Official Site Inspections
http://www.nexgenixpharm.com
- Host name: pages-custom-15.weebly.com
- IP address: 199.34.228.59
- Location: San Francisco United States
- Latitude: 37.7642
- Longitude: -122.3993
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94107